Exosome-based strategies for diagnosis and therapy

Recent Patents on CNS Drug Discovery

Volumn 10, Issue 1, 2015, Pages 10-27

  Urbanelli, L ^a   Buratta, Sandra ^a   Sagini, Krizia ^a   Ferrara, Giuseppina ^a   Lanni, Marco ^a   Emiliani, Carla ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Biomarkers; Circulating nucleic acids; Drug delivery; Exosome like nanoparticles; Exosomes; Extracellular vesicles; Liquid biopsy; Microvesicles; Nanovesicles; Neurodegenerative diseases; Stem cell particles; Theranostics; Tumor diagnosis

Indexed keywords

CELL PROTEIN; LIPID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MICRORNA; MITOCHONDRIAL DNA; NUCLEIC ACID; SMALL INTERFERING RNA;

ANTIGEN PRESENTATION; ARTICLE; CANCER DIAGNOSIS; CARDIOVASCULAR DISEASE; CELL INVASION; CELL ISOLATION; CELL THERAPY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DRUG DELIVERY SYSTEM; ENDOPLASMIC RETICULUM; EXOSOME; GENE DELIVERY SYSTEM; GENETIC ENGINEERING; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION; INNATE IMMUNITY; LIPID COMPOSITION; LIPID RAFT; LIVER CANCER; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; RNA DEGRADATION; STEM CELL; T LYMPHOCYTE; TUMOR DIAGNOSIS; TUMOR ESCAPE; TUMOR PROMOTION; URINARY TRACT DISEASE; ANIMAL; NEOPLASMS; NERVOUS SYSTEM DISEASES; PHYSIOLOGY;

ANIMALS; DRUG DELIVERY SYSTEMS; EXOSOMES; HUMANS; NEOPLASMS; NERVOUS SYSTEM DISEASES;

EID: 84938684548     PISSN: 15748898     EISSN: 22123954     Source Type: Journal    
DOI: 10.2174/1574889810666150702124059     Document Type: Article

References (128)

1. Urbanelli L, Magini A, Buratta S, Brozzi A, Sagini K, Polchi A, et al. Signaling pathways in exosomes biogenesis, secretion and fate. Genes 2013; 4: 152-70.
2. Mathivanan S, Ji H, Simpson RJ. Exosomes: Extracellular organelles important in intercellular communication. J Proteomics 2010; 73: 1907-20.
3. Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in danio rerio. Pharm Res 2015; 32: 2003-14.
4. Kowal J, Tkach M, Thery C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol 2014; 29: 116-25.
5. Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 2014; 3: 26913.
6. Record M, Carayon K, Poirot M, Silvente-Poirot S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta 2014; 1841: 108-20.
7. Subra C, Grand D, Laulagnier K, Stella A, Lambeau G, Paillasse M, et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res 2010; 51: 2105-20.
8. Gezer U, Ozgur E, Cetinkaya M, Isin M, Dalay N. Long noncoding RNAs with low expression levels in cells are enriched in secreted exosomes. Cell Biol Int 2014; 38: 1076-9.
9. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-9.
10. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, Karlsson JM, et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012; 119: 756-66.
11. Guescini M, Guidolin D, Vallorani L, Casadei L, Gioacchini AM, Tibollo P, et al. C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Experimental Cell Research 2010; 316: 1977-84.
12. Thakur BK, Zang H, Becker A, Matei I, Huang Y, Costa-Silva B, et al. Double-stranded DNA in exosomes: A novel biomarker in cancer detection. Cell Research 2014; 24: 766-9.
13. Wiley RD, Gummuluru S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci USA 2006; 103: 738-43.
14. Greening DW, Gopal SK, Xu R, Simpson RJ, Chen W. Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol 2015; 40: 72-81.
15. Demory BM, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics 2013; 12: 343-55.
16. Martins VR, Dias MS, Hainaut P. Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr Opin Oncol 2013; 25: 66-75.
17. Rajendran L, Bali J, Barr MM, Court FA, Kramer-Albers EM, Picou F, et al. Emerging roles of extracellular vesicles in the nervous system. J Neurosci 2014; 34: 15482-9.
18. Lachenal G, Pernet-Gallay K, Chivet M, Hemming FJ, Belly A, Bodon G, et al. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci 2011; 46: 409-18.
19. Coleman BM, Hill AF. Extracellular vesicles - Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases. Semin Cell Dev Biol 2015; 40: 89-96.
20. Turturici G, Tinnirello R, Sconzo G, Geraci F. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: Advantages and disadvantages. Am J Physiol Cell Physiol 2014; 306: C621-33.
21. De Jong OG, Van Balkom BW, Schiffelers RM, Bouten CV, Verhaar MC. Extracellular vesicles: Potential roles in regenerative medicine. Front Immunol 2014; 5: 608.
22. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011; 39: 7223-33.
23. Wagner J, Riwanto M, Besler C, Knau A, Fichtlscherer S, Roxe T, et al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler Thromb Vasc Biol 2013; 33: 1392-400.
24. Dhellin, O., Amigorena, S., Rameau, P., Crouzet, J. Method for preparing membrane vesicles. WO2000044389 (2000).
25. Lamparski, H., Ruegg, C., Le Pecq, J.B., Hsu, D.H., Yao, J.Y. Methods of producing membrane vesicles. WO2001082958 (2001).
26. Lim, S.K. Method of purifying exosomes. WO2012087241 (2012).
27. Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, et al. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J 2009; 23: 1541-57.
28. Vlassov, A., Zeringer, E., Conrad, R. Methods for exosome isolation. WO2013158203 (2013).
29. Gagnon, P.S. Exosome recovery methods with low molecular weight zwitterions. WO2015060784 (2015).
30. Wu, A. Methods and systems for processing exosomes. WO2014078420 (2014).
31. Lapointe, L.C., Pedersen, S.K., McEvoy, A. Method of microvesicle enrichment. WO2012054975 (2012).
32. Skog, J.K., Russo, L. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom. WO2012064993 (2012).
33. Comper, W., Russo, L., Skog, J.K. Nucleic acids extraction from heterogenous biological materials. WO2012155014 (2012).
34. Noerholm, M., Belzer, S., Romain, C., Skog, J.K., Russo, L., Comper, W. Controls for nucleic acids assay. WO2014036391 (2014).
35. Enderle, D., Ramachandran, A., Yan, H., Berghoff, E., Wei, T.F., Noerholm, M., Skog, J.K. Methods for isolating microvesicles. WO2014107571 (2014).
36. Delcayre, A., Le Pecq, J.B. Methods and compounds for the trageting of proteins to exosomes. WO2003016522 (2003).
37. Bond, V.C., Powell, M., Huang, M.B., Ali, S. Compositions and methods for exosome targeted expression. WO2013089738 (2013).
38. Laulagnier K, Motta C, Hamdi S, Roy S, Fauvelle F, Pageaux JF, et al. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem J 2004; 380: 161-71.
39. Paspaliaris, B. A method of producing exosomes. WO2015048844 (2015).
40. Park, D.H., Kang, H.J., Lee, M.Y. Methods of quantifying exosomes in cell culture and method of increasing recovery rate of exosome using the same. US20130157300 (2013).
41. Kim, M.S., Park, D.H., Yoo, C.E., Kim, G.H. Methods of analyzing exosomes using fluorescence-labeled exosomes. US20130302822 (2013).
42. Park, D.H., Kang, H.J., Choi, K.B., Lee, M.Y. Method of quantifying recovery rate of exosome. US20130078658 (2013).
43. Christopherson, R.I., Belov, L., Wissmueller, S., Leong, C. Assay for disease detection. WO2012048372 (2012).
44. Ochiya, T. Method of exosome analysis, eagent for exosome analysis, and analyzer for exosome. US20150017660 (2015).
45. Wong, D.T., Wei, F., Liao, W. Method for exosomal biomarker detection by electric field induced release and measurement. WO2012162563 (2012).
46. Ichiki, T., Akagi, T., Shiono, H. Exosome analysis method, exosome analysis, antibody-exosome complex and exosome electrophoresis chip. WO2014030590 (2014).
47. Itonaga, M., Yagyu, S., Hasegawa, Y., Tsujita, K., Ono, M. Device for sample analysis and method for exosome capture. WO2014168020 (2014).
48. Delcayre, A., Le Pecq, J.B. Exosome ligands, their preparation and uses. WO2007015174 (2007).
49. Ohta, H., Okada, C., Murakami, T., Okamoto, H., Sonoda, H. Monoclonal antibody for detecting exosomes. WO2013099925 (2013).
50. Azorsa, D.O. Hybridoma clones and monoclonal antibody to CD9. WO2014145940 (2014).
51. Azorsa, DO. Hybridoma clones and monoclonal antibodies to tetraspannin 8. WO2014145961 (2014).
52. Properzi F, Logozzi M, Fais S. Exosomes: The future of biomarkers in medicine. Biomark Med 2013; 7: 769-78.
53. Brinton LT, Sloane HS, Kester M, Kelly KA. Formation and role of exosomes in cancer. Cell Mol Life Sci 2014; 72: 659-71.
54. Fais, S., Logozzi, M. A new method to measure and characterize microvesicles in the human body fluids. WO2009092386 (2009).
55. Skolnick, M., Lanchbury, J., Timms, K., Neff, C., Hoff, R., Wang, H., Wagner, S., Sangale, Z. Cancer detection markers. WO2010065968 (2010).
56. Clayton, A. Method. WO2010070276 (2010).
57. Comper, W., Ramachandran, A., Yan, H., Russo, L., Skog, J.K. Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions. WO2014055775 (2014).
58. Taylor, D., Garcel-Taylor, C. Exosome-associated microRNA as a diagnostic marker. WO2009015357 (2009).
59. Taylor, D., Garcel-Taylor, C. Exosome-associated RNA as a diagnostic marker. WO2014160032 (2014).
60. Mitsuhashi, M. Assessment of bone marrow recovery by measuring plasma exoosme mRNAs. US20130172208 (2013).
61. Li G, Shen Q, Li C, Li D, Chen J, He M. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: A systematic review and metaanalysis. Clin Transl Oncol 2015. [Epub ahead of print]
62. Xiao, W., Wang, S., Qu, X., Li, X., Dong, W., Zhao, H. Application of miR26a. CN2014104152566 (2014).
63. Xiao, W., Wang, S., Qu, X., Li, X., Dong, W., Zhao, H. Application of miR 199a. CN2014104152567 (2014).
64. Xiao, W., Wang, S., Qu, X., Li, X., Dong, W., Zhao, H. Blood miRNA marker related to liver cancer and application thereof. CN2014104152452 (2014).
65. Pegtel DM, van de Garde MD, Middeldorp JM. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular crosstalk and immune evasion. Biochim Biophys Acta 2011; 1809: 715- 21.
66. Belting M, Wittrup A. Nanotubes, exosomes, and nucleic acidbinding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: Implications in health and disease. J Cell Biol 2008; 183: 1187-91.
67. Abrignani, S., Pileri, P. Method for the preparation of purified HCV RNA by exosome preparation. WO200136601 (2001).
68. Newman, G.W., Anyanwu, S. Exosome-mediated diagnosis of hepatitis virus infections and diseases. US20140134606 (2014).
69. De Toro J, Herschlik L, Waldner C, Mongini C. Emerging roles of exosomes in normal and pathological conditions: New insights for diagnosis and therapeutic applications. Front Immunol 2015; 6: 203.
70. Yellon DM, Davidson SM. Exosomes Nanoparticles Involved in Cardioprotection? Circulation Research 2014; 114: 325-32.
71. De Kleijn, D., Pasterkamp, G., Timmers, L., Sze, S.K. Exosomal biomarkers for cardiovascular events. WO2012110253 (2012).
72. De Kleijn, D., Pasterkamp, G., Timmers, L., Sze, S.K. Method for diagnosing Acute Coronary Syndrome (ACS). WO2012126531 (2012).
73. Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S, et al. Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease. J Biol Chem 2012; 287: 3842-9.
74. Skog, J.K., Russo, L. Cerebrospinal fluid assay. US20150038335 (2015).
75. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004; 101: 13368-73.
76. Zhou H, Cheruvanky A, Hu X, Matsumoto T, Hiramatsu N, Cho ME, et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 2008; 74: 613-21.
77. Irarrazabal-Munoz, C.E. Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage. WO2013041913 (2013).
78. Mitsuhashi, M., Sharma, K. Urine exosome miRNAs and methods of using same to detect diabetic nephropathy. WO2014055687 (2014).
79. Russo, L. Urine biomarkers. WO2013028788 (2015).
80. Skog, J.K., Noerholm, M. Urine biomarkers cohorts, gene expression signatures, and methods of use thereof. WO2015021158 (2015).
81. Lorenzen JM, Thum T. Circulating and Urinary microRNAs in Kidney Disease. Clinic J Am Soc Nephrol 2012; 7: 1528-33.
82. Felder, R.A., Carlson, J., Gildea, J.J. Compositions and methods for diagnosing and treating salt sensitivity of blood pressure. US20150005290 (2015).
83. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 1987; 262: 9412-20.
84. Thery C, Zitvogel L, Amigorena S. Exosomes: Composition, biogenesis and function. Nat Rev Immunol 2002; 2: 569-79.
85. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996; 183: 1161-72.
86. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, et al. Eradication of established murine tumors using a novel cellfree vaccine: Dendritic cell-derived exosomes. Nat Med 1998; 4: 594-600.
87. Geuze, J.J., Melief, C. Cell derived antigen presenting vesicles. WO1997005900 (1997).
88. Zitvogel, L., Raposo, G., Regnault, A., Amigorena, S. Cellular vesicle called "exosome", preparation and use thereof in immune stimulation. WO1999003499 (1999).
89. Andre F, Chaput N, Schartz NE, Flament C, Aubert N, Bernard J, et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol 2004; 172: 2126- 36.
90. Kim, C.W., Ko, J.K., Cho, J.A. Exosome containing exogenous antigen through gene transcfection and method for utilizing the same. WO 2004014954 (2004).
91. Mamoun, R. Novel chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereof. WO2011036416 (2011).
92. Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 2002; 195: 1303-16.
93. Taylor DD, Gercel-Taylor C, Lyons KS, Stanson J, Whiteside TL. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res 2003; 9: 5113-9.
94. Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z. Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol 2008; 180: 7249-58.
95. Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 2006; 176: 1375-85.
96. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One 2010; 5: e11469.
97. Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res 2006; 66: 9290- 8.
98. Xinag, J. Materials and method of modulating the immune response. US20060233750 (2006).
99. Xiang, J. Materials and Method of Modulating the Immune Response. US20100111916 (2010).
100. Taylor, D., Garcel-Taylor, C. Modification of exosomal components for use as a vaccine. WO2008092153 (2008).
101. Gabrielsson, S. Exosome based treatment of cancer. WO2011000551 (2011).
102. Croce, C.M., Fabbri, M. Methods and compositions related to miR- 21 and miR29a, exosome inhibition and cancer metastasis WO2013090556 (2013).
103. Wulf, G. Exosome inhibiting agents and uses thereof. WO2013014255 (2013).
104. Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, et al. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci USA 2011; 108: 15336-41.
105. Yuyama, K., Igarashi, Y., Mitsutake, S., Yoshida, T., Yamamoto, S. Drugs for diseases associated with amyloid β, and screening thereof. WO2013054534 (2013).
106. Pusic, K.M., Grinberg, Y.Y., Kraig, R.P., Pusic, A.D. Exosomebased therapeutics against neurodegenerative disorders. WO2014028763 (2014).
107. Thibonnier, M. Cell-specific delivery of miRNA modulators for the treatment of obesity and related disorders. WO2014022852 (2014).
108. Mao, J.J., Wan, Y., Jiang, N., Chen, M. Exosome for orofacial diagnostics and therapeutics. WO2014187747 (2014).
109. Ochitani, T., Kosaka, N., Iguchi, H. Nucleic acid introducing method. JP2010285426 (2010).
110. Schmittgen, T.D., Azevedo-Pouly, A.C. Exosome delivery system. WO2015002956 (2015).
111. Akiyoshi, K., Sawada, S., Shiku, H., Harada, N., Seo, N. Nanogel/exosome complex and DDS. WO2014054588 (2014).
112. Ju S, Mu J, Dokland T, Zhuang X, Wang Q, Jiang H, et al. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Mol Ther 2013; 21: 1345-57.
113. Zhang, H. Exosomal compositions and methods for the treatment of disease. WO2011097480 (2011).
114. Einbond, L., Repenti, S. Growth inhibitory effects of nanoparticles containing triterpene glycosides or triterpenes. US20130177627 (2013).
115. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006; 441: 1068-74.
116. Katsuda T, Kosaka N, Takeshita F, Ochiya T. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics 2013; 13: 1637-53.
117. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: Important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-95.
118. Phinney DG, Prockop DJ. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair--current views. Stem Cells 2007; 25: 2896- 902.
119. Lim, S.K. Mesenchymal stem cell particles. WO2009105044 (2009).
120. Lim, S.K. Methods of detecting therapeutic exosomes. WO2012108842 (2012).
121. Lim, S.K., Yeo, M.S.W., Chen, T.S., Lai, R.C. Use of exosomes to promote or enhance hair growth. WO2012053976 (2012).
122. Beelen, D.W., Doppner, T., Felderhoff-Muser, U., Giebel, B., Hermann, D., Horn, P., Keller, M., Kordelas, L., Ludwig, A.K., Rebmann, V. Use of preparations comprising exosomes derived from Mesenchymal Stem Cells (MSCs) in the prevention and therapy of inflammatory conditions. WO2014013029 (2014).
123. Kornblum HI. Introduction to neural stem cells. Stroke 2007; 38: 810-6.
124. Einstein OBen-Hur T. The changing face of neural stem cell therapy in neurologic diseases. Arch Neurol 2008; 65: 452-6.
125. Sinden, J., Stevanato, L., Corteling, R. Stem cell microparticles. WO2014013258 (2014).
126. Stevanato, L., Corteling, R., Sinden, J. Stem cell microparticles and miRNA. WO2014125276 (2014).
127. Hicks, C., Sinden, J., Stevanato, L., Corteling, R. Stem cell microparticles and miRNA. WO2015022545 (2015).
128. Tian, X., Xu, W., Niu, B., Zhang, T., Chen, Y., Wang, J., Zhou, N., Ji, C., Yang, L. Preparation of neural stem cell-derived exosomes, and application of neural stem cell-derived exosomes in nervous system diseases. CN10386573 (2013).